The Adiponectin Paradox in the Elderly: Associations With Body Composition, Physical Functioning, and Mortality

Area of Science:

• Gerontology
• Metabolic Health
• Body Composition

Background:

• Adiponectin, a key metabolic hormone, plays a role in regulating energy homeostasis and inflammation.
• Understanding adiponectin's role in aging is crucial for addressing age-related decline.

Purpose of the Study:

• To investigate the association between adiponectin levels and body composition, weight loss, and physical functioning in the elderly.
• To determine if adiponectin is an independent predictor of incident disability and mortality in older adults.

Main Methods:

• Utilized data from 3,044 participants in the Health, Aging and Body Composition Study.
• Assessed adiponectin levels, body composition (lean mass index, fat mass index, muscle density), weight history, and physical functioning.
• Employed multivariable linear regression and mediation analyses to examine associations.

Main Results:

• Higher baseline adiponectin levels were independently associated with lower fat mass index, lower appendicular lean mass index, reduced muscle density, a history of weight loss, and poorer physical functioning.
• Increased adiponectin levels correlated with a higher risk of incident disability and mortality.
• These associations were fully attenuated when accounting for body composition, muscle density, weight loss, and physical functioning.

Conclusions:

• Elevated serum adiponectin is associated with adverse body composition, reduced muscle mass, and diminished physical function in the elderly.
• While high adiponectin predicts increased risk of disability and death, it is not an independent risk factor when other health parameters are considered.